Geode Capital Management, LLC Sellas Life Sciences Group, Inc. Transaction History
Geode Capital Management, LLC
- $1.52 Trillion
- Q3 2025
A detailed history of Geode Capital Management, LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,264,384 shares of SLS stock, worth $3.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,264,384
Previous 2,200,428
2.91%
Holding current value
$3.24 Million
Previous $4.82 Million
24.8%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding SLS
# of Institutions
100Shares Held
27.8MCall Options Held
3.85MPut Options Held
126K-
Vanguard Group Inc Valley Forge, PA6.84MShares$9.78 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX6.03MShares$8.63 Million1.59% of portfolio
-
Marshall Wace, LLP London, X02.36MShares$3.37 Million0.0% of portfolio
-
State Street Corp Boston, MA1.36MShares$1.95 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.05MShares$1.51 Million0.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $29.4M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...